nifekalant hydrochloride has been researched along with Myocardial Ischemia in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kamakura, S; Kawamura, A; Kurita, T; Miyazaki, S; Morii, I; Myoishi, M; Nonogi, H; Otsuka, Y; Satomi, K; Ueno, K; Yasuda, S | 1 |
| Hotoda, K; Kokaji, K; Kumamaru, H; Okamoto, M | 1 |
| Aoki, K; Asakura, T; Enomoto, Y; Furuta, S; Inai, Y; Toshimitsu, Y | 1 |
| Ando, J; Iwabuchi, M; Kakishita, M; Komura, Y; Nishiyama, K; Nobuyoshi, M; Nosaka, H; Sakai, K; Yasumoto, H; Yokoi, H | 1 |
| Aikawa, M; Handa, S; Iwamoto, T; Iwata, O; Kusuzaki, S; Mori, H; Shinozaki, Y; Tanabe, T | 1 |
5 other study(ies) available for nifekalant hydrochloride and Myocardial Ischemia
| Article | Year |
|---|---|
Intravenous administration of nifekalant hydrochloride for the prevention of ischemia-induced ventricular tachyarrhythmia in patients with renal failure undergoing hemodialysis.
Topics: Aged; Anti-Arrhythmia Agents; Diabetic Nephropathies; Drug Monitoring; Electrocardiography; Humans; Injections, Intravenous; Male; Myocardial Ischemia; Pyrimidinones; Renal Dialysis; Renal Insufficiency; Tachycardia, Ventricular | 2003 |
Experience with nifekalant hydrochloride in a patient with ischemic cardiomyopathy and severe ventricular dysfunction after dor operation.
Topics: Anti-Arrhythmia Agents; Cardiac Surgical Procedures; Cardiomyopathies; Electric Countershock; Humans; Male; Middle Aged; Myocardial Ischemia; Pyrimidinones; Tachycardia, Ventricular; Treatment Outcome; Ventricular Dysfunction, Left | 2004 |
[Nifekalant hydrochloride as an effective treatment for postoperative ischemic heart disease].
Topics: Aged; Anti-Arrhythmia Agents; Coronary Artery Bypass; Female; Humans; Injections, Intravenous; Male; Myocardial Ischemia; Postoperative Complications; Pyrimidinones; Tachycardia, Ventricular | 2005 |
Efficacy of nifekalant hydrochloride in the treatment of fatal ventricular arrhythmia in patients with ischemic heart disease.
Topics: Aged; Anti-Arrhythmia Agents; Drug Administration Schedule; Electrocardiography; Female; Humans; Male; Multivariate Analysis; Myocardial Ischemia; Prognosis; Pyrimidinones; Survival Rate; Tachycardia, Ventricular; Ventricular Fibrillation | 2005 |
Electrophysiologic and blood-flow responses in the endocardium and epicardium to disopyramide and MS-551 during myocardial ischemia in the dog.
Topics: Animals; Anti-Arrhythmia Agents; Blood Pressure; Coronary Circulation; Disopyramide; Dogs; Endocardium; Myocardial Ischemia; Pericardium; Pyrimidinones; Refractory Period, Electrophysiological | 1999 |